Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

CD206-targeted Cy3-Manocept (Mano-Cy3) localizes in nearly all cells present in Kaposi’s sarcoma representing an opportunity for dynamic imaging, local staging and a potential for visceral metastasis imaging

Michael McGrath, Paige Bracci, Rongzhen Zhang, Michael Blue and Frederick Cope
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1681;
Michael McGrath
1AIDS & Cancer Specimen Resource, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paige Bracci
2Univ. of California, San Francisco, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rongzhen Zhang
2Univ. of California, San Francisco, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Blue
3Clinical, Navidea Biopharmaceuticals, Dublin, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederick Cope
3Clinical, Navidea Biopharmaceuticals, Dublin, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 55 no. supplement 1 1681

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 5, 2014.

Copyright & Usage 
© 2014

Author Information

  1. Michael McGrath1,
  2. Paige Bracci2,
  3. Rongzhen Zhang2,
  4. Michael Blue3 and
  5. Frederick Cope3
  1. 1AIDS & Cancer Specimen Resource, San Francisco, CA
  2. 2Univ. of California, San Francisco, San Francisco, CA
  3. 3Clinical, Navidea Biopharmaceuticals, Dublin, OH

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014100
Dec 2014500
Jan 2015100
Apr 2015600
May 2015200
Jun 2015400
Jul 2015200
Sep 20151000
Oct 2015300
Nov 2015300
Jan 2016400
Feb 2016300
Mar 2016900
May 2016100
Jun 2016300
Jul 2016300
Sep 2016700
Oct 2016300
Nov 2016900
Dec 2016600
Jan 2017600
Feb 2017200
Mar 2017500
Apr 20171800
May 2017100
Jun 2017500
Jul 2017400
Aug 2017100
Sep 2017100
Oct 2017400
Nov 2017100
Feb 2018700
Mar 2018400
Apr 2018200
May 2018200
Jul 2018600
Sep 20181600
Oct 2018100
Nov 2018600
Dec 2018300
Feb 2019200
Mar 2019500
Apr 2019600
May 2019900
Jun 20191100
Jul 2019500
Aug 2019800
Sep 2019800
Oct 2019200
Nov 2019200
Dec 2019400
Jan 2020100
Feb 20201000
Mar 20202200
Apr 2020900
May 2020300
Jun 2020200
Jul 2020300
Aug 20202300
Sep 20203300
Oct 20202300
Nov 20203200
Dec 20201200
Jan 2021600
Feb 2021800
Mar 20211800
Apr 20218300
May 20212600
Jun 20211400
Jul 20212400
Aug 20216200
Sep 20211500
Oct 20211400
Nov 20217300
Dec 20214300
Jan 20227500
Feb 20222600
Mar 20223800
Apr 20222600
May 20222300
Jun 2022400
Jul 2022100
Aug 2022400
Sep 2022200
Oct 2022400
Nov 2022200
Jan 2023400
Feb 2023300
Mar 2023400
Apr 2023800
May 2023400
Jun 2023600
Jul 2023200
Aug 2023900
Sep 2023400
Oct 2023500
Nov 2023700
Dec 2023300
Jan 2024900
Feb 2024300
Mar 2024100
Apr 2024400
May 2024300
Jul 2024200
Aug 2024700
Sep 2024700
Oct 2024400
Nov 2024200
Dec 2024200
Jan 2025200
Feb 2025100
Mar 2025400
Apr 2025300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
CD206-targeted Cy3-Manocept (Mano-Cy3) localizes in nearly all cells present in Kaposi’s sarcoma representing an opportunity for dynamic imaging, local staging and a potential for visceral metastasis imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
CD206-targeted Cy3-Manocept (Mano-Cy3) localizes in nearly all cells present in Kaposi’s sarcoma representing an opportunity for dynamic imaging, local staging and a potential for visceral metastasis imaging
Michael McGrath, Paige Bracci, Rongzhen Zhang, Michael Blue, Frederick Cope
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1681;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
CD206-targeted Cy3-Manocept (Mano-Cy3) localizes in nearly all cells present in Kaposi’s sarcoma representing an opportunity for dynamic imaging, local staging and a potential for visceral metastasis imaging
Michael McGrath, Paige Bracci, Rongzhen Zhang, Michael Blue, Frederick Cope
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1681;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • Application of 18F-FDG PET/CT in primary thyroid lymphoma
  • Effect of respiratory gated positron emission tomography on clinical staging and management of lung cancer
  • 18F-FDG PET/CT imaging features of pancreatic solid pseudopapillary tumor
Show more Oncology: Clinical Diagnosis

MTA I: Sarcoma/Melanoma Posters

  • Outcome and response prediction for primary and oligometastatic spinal sarcoma patients who received stereotactic body radiation therapy (SBRT)
  • Value of F-18-FDG PET/CT in the staging, restaging, monitoring of response to therapy and surveillance of uterine leiomyosarcomas.
  • Comparison of Diagnostic Performances of FDG PET/CT and Conventional Imaging Modalities in Undifferentiated Pleomorphic Sarcoma
Show more MTA I: Sarcoma/Melanoma Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire